242 related articles for article (PubMed ID: 35786611)
1. Generation of Human Patient iPSC-derived Retinal Organoids to Model Retinitis Pigmentosa.
Ma C; Jin K; Jin ZB
J Vis Exp; 2022 Jun; (184):. PubMed ID: 35786611
[TBL] [Abstract][Full Text] [Related]
2. Modeling Retinitis Pigmentosa with Patient-Derived iPSCs.
Leong YC; Sowden JC
Adv Exp Med Biol; 2023; 1415():555-563. PubMed ID: 37440086
[TBL] [Abstract][Full Text] [Related]
3. Gene Correction Reverses Ciliopathy and Photoreceptor Loss in iPSC-Derived Retinal Organoids from Retinitis Pigmentosa Patients.
Deng WL; Gao ML; Lei XL; Lv JN; Zhao H; He KW; Xia XX; Li LY; Chen YC; Li YP; Pan D; Xue T; Jin ZB
Stem Cell Reports; 2018 Apr; 10(4):1267-1281. PubMed ID: 29526738
[TBL] [Abstract][Full Text] [Related]
4. Modeling and Rescue of RP2 Retinitis Pigmentosa Using iPSC-Derived Retinal Organoids.
Lane A; Jovanovic K; Shortall C; Ottaviani D; Panes AB; Schwarz N; Guarascio R; Hayes MJ; Palfi A; Chadderton N; Farrar GJ; Hardcastle AJ; Cheetham ME
Stem Cell Reports; 2020 Jul; 15(1):67-79. PubMed ID: 32531192
[TBL] [Abstract][Full Text] [Related]
5. Investigating cone photoreceptor development using patient-derived NRL null retinal organoids.
Kallman A; Capowski EE; Wang J; Kaushik AM; Jansen AD; Edwards KL; Chen L; Berlinicke CA; Joseph Phillips M; Pierce EA; Qian J; Wang TH; Gamm DM; Zack DJ
Commun Biol; 2020 Feb; 3(1):82. PubMed ID: 32081919
[TBL] [Abstract][Full Text] [Related]
6. Application of patient-derived induced pluripotent stem cells and organoids in inherited retinal diseases.
Liang Y; Sun X; Duan C; Tang S; Chen J
Stem Cell Res Ther; 2023 Nov; 14(1):340. PubMed ID: 38012786
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathology of Usher 1B patient-derived retinal organoids at single cell resolution.
Leong YC; Di Foggia V; Pramod H; Bitner-Glindzicz M; Patel A; Sowden JC
Stem Cell Reports; 2022 Nov; 17(11):2421-2437. PubMed ID: 36240775
[TBL] [Abstract][Full Text] [Related]
8. TBC1D32 variants disrupt retinal ciliogenesis and cause retinitis pigmentosa.
Bocquet B; Borday C; Erkilic N; Mamaeva D; Donval A; Masson C; Parain K; Kaminska K; Quinodoz M; Perea-Romero I; Garcia-Garcia G; Jimenez-Medina C; Boukhaddaoui H; Coget A; Leboucq N; Calzetti G; Gandolfi S; Percesepe A; Barili V; Uliana V; Delsante M; Bozzetti F; Scholl HP; Corton M; Ayuso C; Millan JM; Rivolta C; Meunier I; Perron M; Kalatzis V
JCI Insight; 2023 Nov; 8(21):. PubMed ID: 37768732
[TBL] [Abstract][Full Text] [Related]
9. [Toward establishment of regenerative cell therapy for retinitis pigmentosa using iPS cell derived retinal sheet].
Akiba R; Matsuyama T; Takahashi M; Mandai M
Nihon Yakurigaku Zasshi; 2020; 155(2):93-98. PubMed ID: 32115485
[TBL] [Abstract][Full Text] [Related]
10. Patient-specific induced pluripotent stem cells to evaluate the pathophysiology of TRNT1-associated Retinitis pigmentosa.
Sharma TP; Wiley LA; Whitmore SS; Anfinson KR; Cranston CM; Oppedal DJ; Daggett HT; Mullins RF; Tucker BA; Stone EM
Stem Cell Res; 2017 May; 21():58-70. PubMed ID: 28390992
[TBL] [Abstract][Full Text] [Related]
11. Safety and stable survival of stem-cell-derived retinal organoid for 2 years in patients with retinitis pigmentosa.
Hirami Y; Mandai M; Sugita S; Maeda A; Maeda T; Yamamoto M; Uyama H; Yokota S; Fujihara M; Igeta M; Daimon T; Fujita K; Ito T; Shibatani N; Morinaga C; Hayama T; Nakamura A; Ueyama K; Ono K; Ohara H; Fujiwara M; Yamasaki S; Watari K; Bando K; Kawabe K; Ikeda A; Kimura T; Kuwahara A; Takahashi M; Kurimoto Y
Cell Stem Cell; 2023 Dec; 30(12):1585-1596.e6. PubMed ID: 38065067
[TBL] [Abstract][Full Text] [Related]
12. The use of induced pluripotent stem cells to reveal pathogenic gene mutations and explore treatments for retinitis pigmentosa.
Yoshida T; Ozawa Y; Suzuki K; Yuki K; Ohyama M; Akamatsu W; Matsuzaki Y; Shimmura S; Mitani K; Tsubota K; Okano H
Mol Brain; 2014 Jun; 7():45. PubMed ID: 24935155
[TBL] [Abstract][Full Text] [Related]
13. Large-scale phenotypic drug screen identifies neuroprotectants in zebrafish and mouse models of retinitis pigmentosa.
Zhang L; Chen C; Fu J; Lilley B; Berlinicke C; Hansen B; Ding D; Wang G; Wang T; Shou D; Ye Y; Mulligan T; Emmerich K; Saxena MT; Hall KR; Sharrock AV; Brandon C; Park H; Kam TI; Dawson VL; Dawson TM; Shim JS; Hanes J; Ji H; Liu JO; Qian J; Ackerley DF; Rohrer B; Zack DJ; Mumm JS
Elife; 2021 Jun; 10():. PubMed ID: 34184634
[TBL] [Abstract][Full Text] [Related]
14. Rhodopsin-mediated retinitis pigmentosa.
Malanson KM; Lem J
Prog Mol Biol Transl Sci; 2009; 88():1-31. PubMed ID: 20374723
[TBL] [Abstract][Full Text] [Related]
15. Prime Editing Strategy to Install the PRPH2 c.828+1G>A Mutation.
Caruso SM; Tsai YT; da Costa BL; Kolesnikova M; Jenny LA; Tsang SH; Quinn PMJ
Adv Exp Med Biol; 2023; 1415():97-102. PubMed ID: 37440020
[TBL] [Abstract][Full Text] [Related]
16. Human retinal organoids harboring IMPG2 mutations exhibit a photoreceptor outer segment phenotype that models advanced retinitis pigmentosa.
Mayerl SJ; Bajgai S; Ludwig AL; Jager LD; Williams BN; Bacig C; Stoddard C; Sinha D; Philpot BD; Gamm DM
Stem Cell Reports; 2022 Nov; 17(11):2409-2420. PubMed ID: 36206764
[TBL] [Abstract][Full Text] [Related]
17. Generation of CRB1 RP Patient-Derived iPSCs and a CRISPR/Cas9-Mediated Homology-Directed Repair Strategy for the CRB1 c.2480G>T Mutation.
da Costa BL; Li Y; Levi SR; Tsang SH; Quinn PMJ
Adv Exp Med Biol; 2023; 1415():571-576. PubMed ID: 37440088
[TBL] [Abstract][Full Text] [Related]
18. Patient-Specific Retinal Organoids Recapitulate Disease Features of Late-Onset Retinitis Pigmentosa.
Gao ML; Lei XL; Han F; He KW; Jin SQ; Zhang YY; Jin ZB
Front Cell Dev Biol; 2020; 8():128. PubMed ID: 32211407
[TBL] [Abstract][Full Text] [Related]
19. Gene Correction Recovers Phagocytosis in Retinal Pigment Epithelium Derived from Retinitis Pigmentosa-Human-Induced Pluripotent Stem Cells.
Artero-Castro A; Long K; Bassett A; Ávila-Fernandez A; Cortón M; Vidal-Puig A; Jendelova P; Rodriguez-Jimenez FJ; Clemente E; Ayuso C; Erceg S
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672445
[TBL] [Abstract][Full Text] [Related]
20. [Early therapeutic trials for retinitis pigmentosa].
Dufier JL
Bull Acad Natl Med; 2003; 187(9):1685-92; discussion 1692-4. PubMed ID: 15369238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
